Compare UEC & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UEC | NOVT |
|---|---|---|
| Founded | 2003 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Industrial Machinery/Components |
| Sector | Basic Materials | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.0B |
| IPO Year | 2008 | 1999 |
| Metric | UEC | NOVT |
|---|---|---|
| Price | $11.36 | $167.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $18.95 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 8.1M | 428.8K |
| Earning Date | 06-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | $66,837,000.00 | ★ $521,290,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | $220.11 | $6.57 |
| P/E Ratio | ★ N/A | $204.52 |
| Revenue Growth | ★ 29737.95 | 35.49 |
| 52 Week Low | $8.91 | $98.27 |
| 52 Week High | $20.34 | $176.38 |
| Indicator | UEC | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 64.76 |
| Support Level | $9.19 | $146.45 |
| Resistance Level | $12.51 | N/A |
| Average True Range (ATR) | 0.50 | 6.77 |
| MACD | 0.28 | 3.06 |
| Stochastic Oscillator | 86.28 | 81.41 |
Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.